Ascoril D Syrup Should NOT Be Given During Pregnancy
Ascoril D syrup (containing chlorpheniramine, dextromethorphan, and phenylephrine) should be avoided at 5 months of pregnancy due to concerns about phenylephrine, which is a decongestant that lacks adequate safety data in pregnancy and may pose risks to the fetus.
Critical Safety Concerns
Phenylephrine - The Primary Problem
- Phenylephrine is a systemic decongestant that causes vasoconstriction and can potentially reduce placental blood flow
- While one study showed a protective association between decongestants and preterm delivery 1, this does not establish safety for fetal development
- Oral decongestants should be used sparingly during the first trimester 2, and their use later in pregnancy remains inadequately studied
Chlorpheniramine - First-Generation Antihistamine
- First-generation antihistamines like chlorpheniramine should be avoided during pregnancy 2
- These medications cause sedation and have less favorable safety profiles compared to second-generation antihistamines
- Preferred alternatives are cetirizine or loratadine (second-generation antihistamines) 2
Dextromethorphan - Relatively Safer Component
- Dextromethorphan has the most reassuring safety data among the three components
- A controlled study of 184 pregnant women showed no increased risk of major malformations (2.3% vs 2.8% in controls) when used in the first trimester 3
- However, this does not justify using the combination product
Evidence-Based Framework
The 2020 ERS/TSANZ guidelines emphasize that any drug use during pregnancy must balance maternal risk of therapy versus no therapy against fetal risk 4. The guidelines stress:
- Drugs should only be used when direct maternal benefit outweighs potential fetal risk
- For respiratory symptoms, inhaled medications are strongly preferred over systemic agents 4
- The effect of undertreated maternal conditions with resulting hypoxia can harm the fetus 4
Safer Alternatives for Cough and Cold Symptoms
For Cough:
- Dextromethorphan alone (if cough suppressant truly needed) - has better safety data 3
- Inhaled therapies when appropriate for the underlying condition
For Nasal Congestion:
- Intranasal steroids (budesonide is drug of choice) 2
- Saline nasal irrigation (non-pharmacologic)
- Avoid oral decongestants like phenylephrine
For Allergic Symptoms:
- Cetirizine or loratadine (second-generation antihistamines) 2
- NOT chlorpheniramine (first-generation)
Clinical Pitfalls to Avoid
- Do not assume combination products are safe just because individual components may have some safety data
- Avoid first-generation antihistamines - they are sedating and have inferior safety profiles
- Oral decongestants lack robust pregnancy safety data and should be avoided when alternatives exist
- Always consider non-pharmacologic measures first (hydration, humidification, saline rinses)
Bottom Line
At 5 months gestation (second trimester), recommend against Ascoril D syrup. Instead, treat the specific symptom with safer, evidence-based alternatives: cetirizine or loratadine for allergic symptoms, intranasal budesonide for congestion, and dextromethorphan alone only if cough suppression is truly necessary. The combination of a first-generation antihistamine with an oral decongestant presents unnecessary fetal risk when safer alternatives exist.